Skip to main content
Susan Passalaqua, MD, Nuclear Medicine, Gilbert, AZ

Susan Passalaqua MD


Physician

Join to View Full Profile
  • 2946 E Banner Gateway DrGilbert, AZ 85234

  • Phone+1 480-256-6444

  • Fax+1 480-256-4683

Dr. Passalaqua is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Nuclear Medicine, 2000 - 2001
  • Mass General Brigham/Brigham and Women's Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 1999 - 2000
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Radiology-Diagnostic, 1996 - 1999
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineClass of 1996

Certifications & Licensure

  • SD State Medical License
    SD State Medical License Active through 2027
  • AZ State Medical License
    AZ State Medical License 2004 - 2026
  • IA State Medical License
    IA State Medical License 2022 - 2026
  • NE State Medical License
    NE State Medical License 2022 - 2026
  • MN State Medical License
    MN State Medical License 2022 - 2025
  • CA State Medical License
    CA State Medical License 2001 - 2020
  • WA State Medical License
    WA State Medical License Active through 2013
  • Diagnostic Radiology
    American Board of Radiology Diagnostic Radiology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Pivotal Phase 3 SIERRA Trial Data Showing 100% Bone Marrow Transplant Engraftment in Patients Treated with Iomab-B Presented at the 2021 Virtual SNMMI Conference
    Pivotal Phase 3 SIERRA Trial Data Showing 100% Bone Marrow Transplant Engraftment in Patients Treated with Iomab-B Presented at the 2021 Virtual SNMMI ConferenceJune 15th, 2021
  • Banner MD Anderson Offers Drug for Neuroendocrine Cancer
    Banner MD Anderson Offers Drug for Neuroendocrine CancerApril 13th, 2017

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: